U.S. taps Indian pharma, but supply chains still lead back to China
[ad_1] The administration of U.S. President Joe Biden embraced a plan from India’s government last year to edge China out of its position as a leader in making ingredients for generic pharmaceuticals sold in the U.S., but a new report shows that many of those ingredients are likely still coming from China.America’s reliance on China for drug ingredients has raised alarm bells in Congress. House committees will hold two hearings […]